| Literature DB >> 16819550 |
Paul Gregorevic1, James M Allen, Elina Minami, Michael J Blankinship, Miki Haraguchi, Leonard Meuse, Eric Finn, Marvin E Adams, Stanley C Froehner, Charles E Murry, Jeffrey S Chamberlain.
Abstract
Mice carrying mutations in both the dystrophin and utrophin genes die prematurely as a consequence of severe muscular dystrophy. Here, we show that intravascular administration of recombinant adeno-associated viral (rAAV) vectors carrying a microdystrophin gene restores expression of dystrophin in the respiratory, cardiac and limb musculature of these mice, considerably reducing skeletal muscle pathology and extending lifespan. These findings suggest rAAV vector-mediated systemic gene transfer may be useful for treatment of serious neuromuscular disorders such as Duchenne muscular dystrophy.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16819550 PMCID: PMC4244883 DOI: 10.1038/nm1439
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440